nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiothixene—ALB—acquired immunodeficiency syndrome	0.269	1	CbGaD
Thiothixene—SLC22A1—Indinavir—acquired immunodeficiency syndrome	0.0554	0.102	CbGbCtD
Thiothixene—SLC22A1—Nelfinavir—acquired immunodeficiency syndrome	0.0538	0.0989	CbGbCtD
Thiothixene—SLC22A1—Saquinavir—acquired immunodeficiency syndrome	0.0487	0.0895	CbGbCtD
Thiothixene—SLC22A1—Lamivudine—acquired immunodeficiency syndrome	0.0361	0.0664	CbGbCtD
Thiothixene—ALB—Saquinavir—acquired immunodeficiency syndrome	0.0285	0.0524	CbGbCtD
Thiothixene—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0273	0.0502	CbGbCtD
Thiothixene—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0265	0.0486	CbGbCtD
Thiothixene—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0249	0.0457	CbGbCtD
Thiothixene—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0249	0.0457	CbGbCtD
Thiothixene—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0225	0.0414	CbGbCtD
Thiothixene—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0218	0.0401	CbGbCtD
Thiothixene—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0205	0.0377	CbGbCtD
Thiothixene—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0205	0.0377	CbGbCtD
Thiothixene—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0188	0.0347	CbGbCtD
Thiothixene—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0185	0.0341	CbGbCtD
Thiothixene—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0185	0.0341	CbGbCtD
Thiothixene—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.017	0.0313	CbGbCtD
Thiothixene—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.016	0.0294	CbGbCtD
Thiothixene—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0155	0.0286	CbGbCtD
Thiothixene—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.014	0.0258	CbGbCtD
Thiothixene—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.014	0.0258	CbGbCtD
Thiothixene—DRD1—nerve—acquired immunodeficiency syndrome	0.00263	0.0832	CbGeAlD
Thiothixene—DRD2—nerve—acquired immunodeficiency syndrome	0.00155	0.0492	CbGeAlD
Thiothixene—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.0013	0.0411	CbGeAlD
Thiothixene—HTR2A—nerve—acquired immunodeficiency syndrome	0.00102	0.0324	CbGeAlD
Thiothixene—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00099	0.0314	CbGeAlD
Thiothixene—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.000911	0.0288	CbGeAlD
Thiothixene—HTR2A—endothelium—acquired immunodeficiency syndrome	0.000872	0.0276	CbGeAlD
Thiothixene—HTR6—nervous system—acquired immunodeficiency syndrome	0.000794	0.0252	CbGeAlD
Thiothixene—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.000774	0.0245	CbGeAlD
Thiothixene—HTR6—central nervous system—acquired immunodeficiency syndrome	0.000765	0.0242	CbGeAlD
Thiothixene—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000705	0.0223	CbGeAlD
Thiothixene—DRD2—retina—acquired immunodeficiency syndrome	0.000643	0.0204	CbGeAlD
Thiothixene—HTR6—brain—acquired immunodeficiency syndrome	0.000607	0.0192	CbGeAlD
Thiothixene—DRD1—nervous system—acquired immunodeficiency syndrome	0.000591	0.0187	CbGeAlD
Thiothixene—SLC22A1—blood—acquired immunodeficiency syndrome	0.000576	0.0183	CbGeAlD
Thiothixene—DRD1—central nervous system—acquired immunodeficiency syndrome	0.000569	0.018	CbGeAlD
Thiothixene—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000545	0.0173	CbGeAlD
Thiothixene—SLC22A1—vagina—acquired immunodeficiency syndrome	0.000534	0.0169	CbGeAlD
Thiothixene—SLC22A1—nervous system—acquired immunodeficiency syndrome	0.000468	0.0148	CbGeAlD
Thiothixene—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000459	0.0145	CbGeAlD
Thiothixene—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000459	0.0145	CbGeAlD
Thiothixene—DRD1—brain—acquired immunodeficiency syndrome	0.000452	0.0143	CbGeAlD
Thiothixene—SLC22A1—central nervous system—acquired immunodeficiency syndrome	0.00045	0.0143	CbGeAlD
Thiothixene—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000442	0.014	CbGeAlD
Thiothixene—HTR2A—retina—acquired immunodeficiency syndrome	0.000424	0.0134	CbGeAlD
Thiothixene—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000386	0.0122	CbGeAlD
Thiothixene—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000381	0.0121	CbGeAlD
Thiothixene—DRD2—lung—acquired immunodeficiency syndrome	0.000377	0.0119	CbGeAlD
Thiothixene—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000372	0.0118	CbGeAlD
Thiothixene—CYP1A2—blood—acquired immunodeficiency syndrome	0.000363	0.0115	CbGeAlD
Thiothixene—SLC22A1—brain—acquired immunodeficiency syndrome	0.000358	0.0113	CbGeAlD
Thiothixene—HRH1—digestive system—acquired immunodeficiency syndrome	0.000357	0.0113	CbGeAlD
Thiothixene—HTR2C—brain—acquired immunodeficiency syndrome	0.000351	0.0111	CbGeAlD
Thiothixene—DRD2—nervous system—acquired immunodeficiency syndrome	0.000349	0.0111	CbGeAlD
Thiothixene—ALB—brain—acquired immunodeficiency syndrome	0.000342	0.0108	CbGeAlD
Thiothixene—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000336	0.0106	CbGeAlD
Thiothixene—ADRA2A—blood—acquired immunodeficiency syndrome	0.000334	0.0106	CbGeAlD
Thiothixene—ALB—lymph node—acquired immunodeficiency syndrome	0.000331	0.0105	CbGeAlD
Thiothixene—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.000322	0.00233	CcSEcCtD
Thiothixene—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000321	0.0102	CbGeAlD
Thiothixene—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.00032	0.00232	CcSEcCtD
Thiothixene—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000318	0.00231	CcSEcCtD
Thiothixene—CYP1A2—lung—acquired immunodeficiency syndrome	0.000318	0.0101	CbGeAlD
Thiothixene—Loss of consciousness—Indinavir—acquired immunodeficiency syndrome	0.000318	0.0023	CcSEcCtD
Thiothixene—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000317	0.0023	CcSEcCtD
Thiothixene—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000317	0.0023	CcSEcCtD
Thiothixene—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000315	0.00229	CcSEcCtD
Thiothixene—Cough—Indinavir—acquired immunodeficiency syndrome	0.000315	0.00229	CcSEcCtD
Thiothixene—HRH1—vagina—acquired immunodeficiency syndrome	0.000315	0.00997	CbGeAlD
Thiothixene—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000315	0.00228	CcSEcCtD
Thiothixene—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.000314	0.00228	CcSEcCtD
Thiothixene—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.000314	0.00227	CcSEcCtD
Thiothixene—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000312	0.00226	CcSEcCtD
Thiothixene—Constipation—Stavudine—acquired immunodeficiency syndrome	0.000312	0.00226	CcSEcCtD
Thiothixene—Shock—Zidovudine—acquired immunodeficiency syndrome	0.000312	0.00226	CcSEcCtD
Thiothixene—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000311	0.00225	CcSEcCtD
Thiothixene—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.00031	0.00225	CcSEcCtD
Thiothixene—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00031	0.00224	CcSEcCtD
Thiothixene—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000309	0.00979	CbGeAlD
Thiothixene—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.000308	0.00223	CcSEcCtD
Thiothixene—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000307	0.00222	CcSEcCtD
Thiothixene—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.000306	0.00222	CcSEcCtD
Thiothixene—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000302	0.00219	CcSEcCtD
Thiothixene—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000302	0.00218	CcSEcCtD
Thiothixene—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.000301	0.00218	CcSEcCtD
Thiothixene—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.0003	0.00218	CcSEcCtD
Thiothixene—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.0003	0.00218	CcSEcCtD
Thiothixene—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.0003	0.00217	CcSEcCtD
Thiothixene—Cough—Efavirenz—acquired immunodeficiency syndrome	0.000298	0.00216	CcSEcCtD
Thiothixene—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000298	0.00943	CbGeAlD
Thiothixene—HRH1—lung—acquired immunodeficiency syndrome	0.000298	0.00943	CbGeAlD
Thiothixene—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000297	0.00215	CcSEcCtD
Thiothixene—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000296	0.00214	CcSEcCtD
Thiothixene—HTR1A—brain—acquired immunodeficiency syndrome	0.000295	0.00935	CbGeAlD
Thiothixene—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000295	0.00214	CcSEcCtD
Thiothixene—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000293	0.00212	CcSEcCtD
Thiothixene—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.000293	0.00212	CcSEcCtD
Thiothixene—ADRA2A—lung—acquired immunodeficiency syndrome	0.000292	0.00926	CbGeAlD
Thiothixene—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000292	0.00212	CcSEcCtD
Thiothixene—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000291	0.00211	CcSEcCtD
Thiothixene—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000291	0.00211	CcSEcCtD
Thiothixene—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.00029	0.0021	CcSEcCtD
Thiothixene—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00029	0.0021	CcSEcCtD
Thiothixene—Shock—Indinavir—acquired immunodeficiency syndrome	0.00029	0.0021	CcSEcCtD
Thiothixene—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00029	0.0021	CcSEcCtD
Thiothixene—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000289	0.00209	CcSEcCtD
Thiothixene—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000288	0.00208	CcSEcCtD
Thiothixene—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000287	0.00208	CcSEcCtD
Thiothixene—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000287	0.00208	CcSEcCtD
Thiothixene—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000286	0.00207	CcSEcCtD
Thiothixene—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000285	0.00207	CcSEcCtD
Thiothixene—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000285	0.00207	CcSEcCtD
Thiothixene—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000285	0.00206	CcSEcCtD
Thiothixene—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000284	0.00206	CcSEcCtD
Thiothixene—HTR2A—blood—acquired immunodeficiency syndrome	0.000284	0.00898	CbGeAlD
Thiothixene—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000283	0.00205	CcSEcCtD
Thiothixene—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000282	0.00204	CcSEcCtD
Thiothixene—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000281	0.00204	CcSEcCtD
Thiothixene—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.00028	0.00203	CcSEcCtD
Thiothixene—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000278	0.00202	CcSEcCtD
Thiothixene—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000278	0.00201	CcSEcCtD
Thiothixene—HRH1—nervous system—acquired immunodeficiency syndrome	0.000276	0.00873	CbGeAlD
Thiothixene—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000276	0.002	CcSEcCtD
Thiothixene—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000274	0.00199	CcSEcCtD
Thiothixene—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000274	0.00198	CcSEcCtD
Thiothixene—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000273	0.00198	CcSEcCtD
Thiothixene—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000273	0.00866	CbGeAlD
Thiothixene—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000273	0.00198	CcSEcCtD
Thiothixene—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000272	0.00197	CcSEcCtD
Thiothixene—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000272	0.00197	CcSEcCtD
Thiothixene—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000271	0.00859	CbGeAlD
Thiothixene—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000271	0.00197	CcSEcCtD
Thiothixene—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000271	0.00196	CcSEcCtD
Thiothixene—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000271	0.00196	CcSEcCtD
Thiothixene—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000271	0.00858	CbGeAlD
Thiothixene—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.00196	CcSEcCtD
Thiothixene—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00027	0.00195	CcSEcCtD
Thiothixene—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000269	0.00195	CcSEcCtD
Thiothixene—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000269	0.00195	CcSEcCtD
Thiothixene—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000267	0.00194	CcSEcCtD
Thiothixene—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000267	0.00194	CcSEcCtD
Thiothixene—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000267	0.00194	CcSEcCtD
Thiothixene—DRD2—brain—acquired immunodeficiency syndrome	0.000267	0.00845	CbGeAlD
Thiothixene—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000267	0.00193	CcSEcCtD
Thiothixene—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000267	0.00193	CcSEcCtD
Thiothixene—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000266	0.00192	CcSEcCtD
Thiothixene—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000266	0.00192	CcSEcCtD
Thiothixene—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000265	0.00841	CbGeAlD
Thiothixene—Rash—Didanosine—acquired immunodeficiency syndrome	0.000265	0.00192	CcSEcCtD
Thiothixene—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000265	0.00192	CcSEcCtD
Thiothixene—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000265	0.00192	CcSEcCtD
Thiothixene—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000264	0.00191	CcSEcCtD
Thiothixene—HTR2A—vagina—acquired immunodeficiency syndrome	0.000263	0.00833	CbGeAlD
Thiothixene—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000263	0.00191	CcSEcCtD
Thiothixene—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000263	0.0019	CcSEcCtD
Thiothixene—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000262	0.0019	CcSEcCtD
Thiothixene—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000262	0.0019	CcSEcCtD
Thiothixene—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000262	0.0019	CcSEcCtD
Thiothixene—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000262	0.0019	CcSEcCtD
Thiothixene—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000261	0.00189	CcSEcCtD
Thiothixene—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000261	0.00826	CbGeAlD
Thiothixene—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000261	0.00189	CcSEcCtD
Thiothixene—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.00189	CcSEcCtD
Thiothixene—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00026	0.00189	CcSEcCtD
Thiothixene—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000259	0.00188	CcSEcCtD
Thiothixene—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000259	0.00187	CcSEcCtD
Thiothixene—CYP2D6—blood—acquired immunodeficiency syndrome	0.000258	0.00818	CbGeAlD
Thiothixene—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000258	0.00187	CcSEcCtD
Thiothixene—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000258	0.00187	CcSEcCtD
Thiothixene—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000258	0.00187	CcSEcCtD
Thiothixene—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000256	0.00186	CcSEcCtD
Thiothixene—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000256	0.00185	CcSEcCtD
Thiothixene—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000254	0.00184	CcSEcCtD
Thiothixene—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000254	0.00184	CcSEcCtD
Thiothixene—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000254	0.00184	CcSEcCtD
Thiothixene—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000254	0.00184	CcSEcCtD
Thiothixene—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000252	0.00183	CcSEcCtD
Thiothixene—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000252	0.00183	CcSEcCtD
Thiothixene—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000252	0.00183	CcSEcCtD
Thiothixene—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000252	0.00183	CcSEcCtD
Thiothixene—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.00182	CcSEcCtD
Thiothixene—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00025	0.00181	CcSEcCtD
Thiothixene—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00025	0.00181	CcSEcCtD
Thiothixene—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00025	0.00181	CcSEcCtD
Thiothixene—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.00181	CcSEcCtD
Thiothixene—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000249	0.0018	CcSEcCtD
Thiothixene—HTR2A—lung—acquired immunodeficiency syndrome	0.000249	0.00788	CbGeAlD
Thiothixene—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000248	0.0018	CcSEcCtD
Thiothixene—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.0018	CcSEcCtD
Thiothixene—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000248	0.0018	CcSEcCtD
Thiothixene—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000246	0.00178	CcSEcCtD
Thiothixene—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000244	0.00177	CcSEcCtD
Thiothixene—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000243	0.00176	CcSEcCtD
Thiothixene—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000242	0.00176	CcSEcCtD
Thiothixene—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000242	0.00175	CcSEcCtD
Thiothixene—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000242	0.00175	CcSEcCtD
Thiothixene—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000242	0.00175	CcSEcCtD
Thiothixene—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.00175	CcSEcCtD
Thiothixene—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000241	0.00175	CcSEcCtD
Thiothixene—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000241	0.00175	CcSEcCtD
Thiothixene—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.00174	CcSEcCtD
Thiothixene—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00024	0.00174	CcSEcCtD
Thiothixene—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00024	0.00174	CcSEcCtD
Thiothixene—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00024	0.00174	CcSEcCtD
Thiothixene—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000238	0.00173	CcSEcCtD
Thiothixene—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000238	0.00173	CcSEcCtD
Thiothixene—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000238	0.00173	CcSEcCtD
Thiothixene—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000238	0.00172	CcSEcCtD
Thiothixene—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000238	0.00172	CcSEcCtD
Thiothixene—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000238	0.00172	CcSEcCtD
Thiothixene—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000237	0.00172	CcSEcCtD
Thiothixene—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000235	0.0017	CcSEcCtD
Thiothixene—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000234	0.0017	CcSEcCtD
Thiothixene—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.00169	CcSEcCtD
Thiothixene—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000233	0.00169	CcSEcCtD
Thiothixene—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.00168	CcSEcCtD
Thiothixene—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000232	0.00168	CcSEcCtD
Thiothixene—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000232	0.00168	CcSEcCtD
Thiothixene—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000231	0.00167	CcSEcCtD
Thiothixene—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000231	0.00167	CcSEcCtD
Thiothixene—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000231	0.00167	CcSEcCtD
Thiothixene—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.00167	CcSEcCtD
Thiothixene—HTR2A—nervous system—acquired immunodeficiency syndrome	0.00023	0.00729	CbGeAlD
Thiothixene—Rash—Stavudine—acquired immunodeficiency syndrome	0.00023	0.00167	CcSEcCtD
Thiothixene—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.00023	0.00167	CcSEcCtD
Thiothixene—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00023	0.00167	CcSEcCtD
Thiothixene—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.00166	CcSEcCtD
Thiothixene—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000229	0.00166	CcSEcCtD
Thiothixene—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000228	0.00165	CcSEcCtD
Thiothixene—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000228	0.00165	CcSEcCtD
Thiothixene—Rash—Abacavir—acquired immunodeficiency syndrome	0.000227	0.00164	CcSEcCtD
Thiothixene—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000226	0.00164	CcSEcCtD
Thiothixene—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000226	0.00164	CcSEcCtD
Thiothixene—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000226	0.00164	CcSEcCtD
Thiothixene—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000224	0.00163	CcSEcCtD
Thiothixene—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000224	0.00163	CcSEcCtD
Thiothixene—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000223	0.00162	CcSEcCtD
Thiothixene—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000223	0.00161	CcSEcCtD
Thiothixene—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.00161	CcSEcCtD
Thiothixene—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000222	0.00702	CbGeAlD
Thiothixene—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.00161	CcSEcCtD
Thiothixene—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000221	0.0016	CcSEcCtD
Thiothixene—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00022	0.00159	CcSEcCtD
Thiothixene—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000219	0.00159	CcSEcCtD
Thiothixene—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000219	0.00159	CcSEcCtD
Thiothixene—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000217	0.00158	CcSEcCtD
Thiothixene—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000217	0.00157	CcSEcCtD
Thiothixene—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000217	0.00157	CcSEcCtD
Thiothixene—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000217	0.00157	CcSEcCtD
Thiothixene—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000216	0.00156	CcSEcCtD
Thiothixene—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000215	0.00156	CcSEcCtD
Thiothixene—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.00155	CcSEcCtD
Thiothixene—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000214	0.00155	CcSEcCtD
Thiothixene—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000213	0.00154	CcSEcCtD
Thiothixene—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000212	0.00153	CcSEcCtD
Thiothixene—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000212	0.00153	CcSEcCtD
Thiothixene—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000212	0.00153	CcSEcCtD
Thiothixene—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.00153	CcSEcCtD
Thiothixene—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000211	0.00153	CcSEcCtD
Thiothixene—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.00153	CcSEcCtD
Thiothixene—HRH1—brain—acquired immunodeficiency syndrome	0.000211	0.00667	CbGeAlD
Thiothixene—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.00021	0.00664	CbGeAlD
Thiothixene—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00021	0.00152	CcSEcCtD
Thiothixene—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000209	0.00151	CcSEcCtD
Thiothixene—ADRA2A—brain—acquired immunodeficiency syndrome	0.000207	0.00656	CbGeAlD
Thiothixene—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.00149	CcSEcCtD
Thiothixene—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000205	0.00149	CcSEcCtD
Thiothixene—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000205	0.00148	CcSEcCtD
Thiothixene—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.00148	CcSEcCtD
Thiothixene—HRH1—lymph node—acquired immunodeficiency syndrome	0.000204	0.00645	CbGeAlD
Thiothixene—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.00147	CcSEcCtD
Thiothixene—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000202	0.0064	CbGeAlD
Thiothixene—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000202	0.00146	CcSEcCtD
Thiothixene—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000202	0.00146	CcSEcCtD
Thiothixene—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000202	0.00146	CcSEcCtD
Thiothixene—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000201	0.00146	CcSEcCtD
Thiothixene—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.0002	0.00633	CbGeAlD
Thiothixene—Rash—Zidovudine—acquired immunodeficiency syndrome	0.0002	0.00145	CcSEcCtD
Thiothixene—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.0002	0.00145	CcSEcCtD
Thiothixene—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.0002	0.00145	CcSEcCtD
Thiothixene—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000197	0.00143	CcSEcCtD
Thiothixene—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.00143	CcSEcCtD
Thiothixene—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000196	0.00142	CcSEcCtD
Thiothixene—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000196	0.00142	CcSEcCtD
Thiothixene—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000195	0.00141	CcSEcCtD
Thiothixene—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000195	0.00141	CcSEcCtD
Thiothixene—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.0014	CcSEcCtD
Thiothixene—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.00139	CcSEcCtD
Thiothixene—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000191	0.00138	CcSEcCtD
Thiothixene—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000189	0.00137	CcSEcCtD
Thiothixene—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.00137	CcSEcCtD
Thiothixene—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000188	0.00136	CcSEcCtD
Thiothixene—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000188	0.00136	CcSEcCtD
Thiothixene—Rash—Indinavir—acquired immunodeficiency syndrome	0.000186	0.00135	CcSEcCtD
Thiothixene—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000186	0.00135	CcSEcCtD
Thiothixene—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000184	0.00134	CcSEcCtD
Thiothixene—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.00132	CcSEcCtD
Thiothixene—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.00132	CcSEcCtD
Thiothixene—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00018	0.0013	CcSEcCtD
Thiothixene—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000177	0.00128	CcSEcCtD
Thiothixene—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.00128	CcSEcCtD
Thiothixene—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000176	0.00128	CcSEcCtD
Thiothixene—HTR2A—brain—acquired immunodeficiency syndrome	0.000176	0.00557	CbGeAlD
Thiothixene—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000176	0.00127	CcSEcCtD
Thiothixene—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000176	0.00127	CcSEcCtD
Thiothixene—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000175	0.00127	CcSEcCtD
Thiothixene—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.00127	CcSEcCtD
Thiothixene—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.00126	CcSEcCtD
Thiothixene—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.00123	CcSEcCtD
Thiothixene—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00017	0.00123	CcSEcCtD
Thiothixene—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000169	0.00122	CcSEcCtD
Thiothixene—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000168	0.00122	CcSEcCtD
Thiothixene—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000168	0.00122	CcSEcCtD
Thiothixene—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.00122	CcSEcCtD
Thiothixene—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.00121	CcSEcCtD
Thiothixene—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.0012	CcSEcCtD
Thiothixene—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.00118	CcSEcCtD
Thiothixene—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.00118	CcSEcCtD
Thiothixene—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.00118	CcSEcCtD
Thiothixene—CYP2D6—brain—acquired immunodeficiency syndrome	0.00016	0.00508	CbGeAlD
Thiothixene—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.00116	CcSEcCtD
Thiothixene—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.00115	CcSEcCtD
Thiothixene—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.00114	CcSEcCtD
Thiothixene—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.00114	CcSEcCtD
Thiothixene—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.00113	CcSEcCtD
Thiothixene—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.00113	CcSEcCtD
Thiothixene—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.00112	CcSEcCtD
Thiothixene—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.00109	CcSEcCtD
Thiothixene—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.00108	CcSEcCtD
Thiothixene—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.00108	CcSEcCtD
Thiothixene—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.00108	CcSEcCtD
Thiothixene—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.00106	CcSEcCtD
Thiothixene—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.00104	CcSEcCtD
Thiothixene—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.00103	CcSEcCtD
Thiothixene—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.00103	CcSEcCtD
Thiothixene—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.00102	CcSEcCtD
Thiothixene—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000974	CcSEcCtD
Thiothixene—Acepromazine—ALB—acquired immunodeficiency syndrome	6.46e-05	0.251	CrCbGaD
Thiothixene—Thioproperazine—ALB—acquired immunodeficiency syndrome	6.32e-05	0.246	CrCbGaD
Thiothixene—Pipotiazine—ALB—acquired immunodeficiency syndrome	6.22e-05	0.242	CrCbGaD
Thiothixene—Chlorpromazine—ALB—acquired immunodeficiency syndrome	3.37e-05	0.131	CrCbGaD
Thiothixene—Amitriptyline—ALB—acquired immunodeficiency syndrome	3.33e-05	0.13	CrCbGaD
Thiothixene—ADRA2A—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	2.43e-05	0.00139	CbGpPWpGaD
Thiothixene—HTR1A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	2.41e-05	0.00138	CbGpPWpGaD
Thiothixene—ALB—Folate Metabolism—IL6—acquired immunodeficiency syndrome	2.4e-05	0.00137	CbGpPWpGaD
Thiothixene—HTR2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	2.39e-05	0.00137	CbGpPWpGaD
Thiothixene—DRD1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.39e-05	0.00137	CbGpPWpGaD
Thiothixene—DRD1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.39e-05	0.00137	CbGpPWpGaD
Thiothixene—HRH1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	2.39e-05	0.00137	CbGpPWpGaD
Thiothixene—ALB—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	2.36e-05	0.00135	CbGpPWpGaD
Thiothixene—DRD1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.31e-05	0.00132	CbGpPWpGaD
Thiothixene—ALB—Metabolism—TAT—acquired immunodeficiency syndrome	2.29e-05	0.00131	CbGpPWpGaD
Thiothixene—DRD1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.21e-05	0.00127	CbGpPWpGaD
Thiothixene—HTR1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.2e-05	0.00126	CbGpPWpGaD
Thiothixene—DRD2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.19e-05	0.00126	CbGpPWpGaD
Thiothixene—HTR1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.19e-05	0.00125	CbGpPWpGaD
Thiothixene—HTR2C—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.19e-05	0.00125	CbGpPWpGaD
Thiothixene—HTR2C—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.18e-05	0.00125	CbGpPWpGaD
Thiothixene—ADRA2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	2.18e-05	0.00125	CbGpPWpGaD
Thiothixene—DRD1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.17e-05	0.00124	CbGpPWpGaD
Thiothixene—DRD1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.17e-05	0.00124	CbGpPWpGaD
Thiothixene—HTR2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.16e-05	0.00124	CbGpPWpGaD
Thiothixene—HRH1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.15e-05	0.00123	CbGpPWpGaD
Thiothixene—HTR6—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.12e-05	0.00121	CbGpPWpGaD
Thiothixene—HTR1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.1e-05	0.0012	CbGpPWpGaD
Thiothixene—HTR1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.1e-05	0.0012	CbGpPWpGaD
Thiothixene—HTR2C—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.09e-05	0.0012	CbGpPWpGaD
Thiothixene—HTR2C—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.09e-05	0.0012	CbGpPWpGaD
Thiothixene—HTR6—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.08e-05	0.00119	CbGpPWpGaD
Thiothixene—HTR2A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	2.08e-05	0.00119	CbGpPWpGaD
Thiothixene—HTR1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.06e-05	0.00118	CbGpPWpGaD
Thiothixene—HTR1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.06e-05	0.00118	CbGpPWpGaD
Thiothixene—HTR2C—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.05e-05	0.00117	CbGpPWpGaD
Thiothixene—HTR2C—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.05e-05	0.00117	CbGpPWpGaD
Thiothixene—HTR1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.99e-05	0.00114	CbGpPWpGaD
Thiothixene—HTR2C—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.98e-05	0.00113	CbGpPWpGaD
Thiothixene—ADRA2A—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	1.97e-05	0.00113	CbGpPWpGaD
Thiothixene—ADRA2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	1.96e-05	0.00112	CbGpPWpGaD
Thiothixene—ALB—Metabolism—AGPS—acquired immunodeficiency syndrome	1.95e-05	0.00112	CbGpPWpGaD
Thiothixene—HTR1A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	1.94e-05	0.00111	CbGpPWpGaD
Thiothixene—ALB—Hemostasis—IFNA1—acquired immunodeficiency syndrome	1.93e-05	0.00111	CbGpPWpGaD
Thiothixene—DRD2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.93e-05	0.00111	CbGpPWpGaD
Thiothixene—DRD2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.92e-05	0.0011	CbGpPWpGaD
Thiothixene—HTR6—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.92e-05	0.0011	CbGpPWpGaD
Thiothixene—ADRA2A—Hemostasis—CSF2—acquired immunodeficiency syndrome	1.92e-05	0.0011	CbGpPWpGaD
Thiothixene—HTR6—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.91e-05	0.00109	CbGpPWpGaD
Thiothixene—ALB—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	1.91e-05	0.00109	CbGpPWpGaD
Thiothixene—HTR1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.9e-05	0.00109	CbGpPWpGaD
Thiothixene—HTR2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.9e-05	0.00109	CbGpPWpGaD
Thiothixene—HRH1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.9e-05	0.00109	CbGpPWpGaD
Thiothixene—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	1.89e-05	0.00108	CbGpPWpGaD
Thiothixene—HTR6—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.89e-05	0.00108	CbGpPWpGaD
Thiothixene—HTR2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.89e-05	0.00108	CbGpPWpGaD
Thiothixene—HTR2C—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.89e-05	0.00108	CbGpPWpGaD
Thiothixene—HRH1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.89e-05	0.00108	CbGpPWpGaD
Thiothixene—HTR1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.87e-05	0.00107	CbGpPWpGaD
Thiothixene—HTR1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.87e-05	0.00107	CbGpPWpGaD
Thiothixene—HTR2C—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.86e-05	0.00107	CbGpPWpGaD
Thiothixene—HTR2C—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.86e-05	0.00107	CbGpPWpGaD
Thiothixene—DRD2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.85e-05	0.00106	CbGpPWpGaD
Thiothixene—DRD2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.85e-05	0.00106	CbGpPWpGaD
Thiothixene—DRD1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	1.85e-05	0.00106	CbGpPWpGaD
Thiothixene—DRD1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.82e-05	0.00104	CbGpPWpGaD
Thiothixene—HTR2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.82e-05	0.00104	CbGpPWpGaD
Thiothixene—HTR2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.82e-05	0.00104	CbGpPWpGaD
Thiothixene—HRH1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.81e-05	0.00104	CbGpPWpGaD
Thiothixene—HRH1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.81e-05	0.00104	CbGpPWpGaD
Thiothixene—DRD2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.81e-05	0.00104	CbGpPWpGaD
Thiothixene—DRD2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.81e-05	0.00104	CbGpPWpGaD
Thiothixene—DRD1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.79e-05	0.00103	CbGpPWpGaD
Thiothixene—HTR2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.78e-05	0.00102	CbGpPWpGaD
Thiothixene—HTR2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.78e-05	0.00102	CbGpPWpGaD
Thiothixene—HRH1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.77e-05	0.00102	CbGpPWpGaD
Thiothixene—HRH1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.77e-05	0.00102	CbGpPWpGaD
Thiothixene—HTR6—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.75e-05	0.001	CbGpPWpGaD
Thiothixene—DRD2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.75e-05	0.001	CbGpPWpGaD
Thiothixene—HTR6—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.73e-05	0.000991	CbGpPWpGaD
Thiothixene—ADRA2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.73e-05	0.00099	CbGpPWpGaD
Thiothixene—ADRA2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.72e-05	0.000986	CbGpPWpGaD
Thiothixene—HTR2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.72e-05	0.000984	CbGpPWpGaD
Thiothixene—HRH1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.71e-05	0.000982	CbGpPWpGaD
Thiothixene—HTR2A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	1.68e-05	0.000962	CbGpPWpGaD
Thiothixene—DRD2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.67e-05	0.000956	CbGpPWpGaD
Thiothixene—DRD1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.65e-05	0.000947	CbGpPWpGaD
Thiothixene—ADRA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.65e-05	0.000946	CbGpPWpGaD
Thiothixene—ADRA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.65e-05	0.000946	CbGpPWpGaD
Thiothixene—HTR2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.64e-05	0.000941	CbGpPWpGaD
Thiothixene—DRD2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.64e-05	0.00094	CbGpPWpGaD
Thiothixene—DRD2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.64e-05	0.00094	CbGpPWpGaD
Thiothixene—DRD1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.64e-05	0.00094	CbGpPWpGaD
Thiothixene—HRH1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.64e-05	0.000939	CbGpPWpGaD
Thiothixene—DRD1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.63e-05	0.000933	CbGpPWpGaD
Thiothixene—ADRA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.62e-05	0.000927	CbGpPWpGaD
Thiothixene—ADRA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.62e-05	0.000927	CbGpPWpGaD
Thiothixene—HTR2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.61e-05	0.000925	CbGpPWpGaD
Thiothixene—HTR2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.61e-05	0.000925	CbGpPWpGaD
Thiothixene—HRH1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.61e-05	0.000923	CbGpPWpGaD
Thiothixene—HRH1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.61e-05	0.000923	CbGpPWpGaD
Thiothixene—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	1.61e-05	0.000922	CbGpPWpGaD
Thiothixene—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	1.6e-05	0.000919	CbGpPWpGaD
Thiothixene—HTR6—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.59e-05	0.000909	CbGpPWpGaD
Thiothixene—HTR1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.57e-05	0.000897	CbGpPWpGaD
Thiothixene—ADRA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.56e-05	0.000895	CbGpPWpGaD
Thiothixene—HTR2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.56e-05	0.000892	CbGpPWpGaD
Thiothixene—ALB—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	1.55e-05	0.000889	CbGpPWpGaD
Thiothixene—HTR1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.54e-05	0.000883	CbGpPWpGaD
Thiothixene—HTR2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.53e-05	0.000879	CbGpPWpGaD
Thiothixene—ALB—Hemostasis—CSF2—acquired immunodeficiency syndrome	1.51e-05	0.000867	CbGpPWpGaD
Thiothixene—DRD1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.51e-05	0.000865	CbGpPWpGaD
Thiothixene—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.5e-05	0.000857	CbGpPWpGaD
Thiothixene—ADRA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.49e-05	0.000856	CbGpPWpGaD
Thiothixene—HTR6—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.49e-05	0.000854	CbGpPWpGaD
Thiothixene—HTR6—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.49e-05	0.000854	CbGpPWpGaD
Thiothixene—DRD1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.49e-05	0.000853	CbGpPWpGaD
Thiothixene—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.47e-05	0.000841	CbGpPWpGaD
Thiothixene—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.47e-05	0.000841	CbGpPWpGaD
Thiothixene—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.42e-05	0.000814	CbGpPWpGaD
Thiothixene—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.41e-05	0.00081	CbGpPWpGaD
Thiothixene—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.41e-05	0.000808	CbGpPWpGaD
Thiothixene—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.4e-05	0.000804	CbGpPWpGaD
Thiothixene—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.4e-05	0.000802	CbGpPWpGaD
Thiothixene—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.39e-05	0.000798	CbGpPWpGaD
Thiothixene—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	1.39e-05	0.000798	CbGpPWpGaD
Thiothixene—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.37e-05	0.000787	CbGpPWpGaD
Thiothixene—DRD1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.37e-05	0.000782	CbGpPWpGaD
Thiothixene—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	1.36e-05	0.000781	CbGpPWpGaD
Thiothixene—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.35e-05	0.000776	CbGpPWpGaD
Thiothixene—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.35e-05	0.000775	CbGpPWpGaD
Thiothixene—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.35e-05	0.000773	CbGpPWpGaD
Thiothixene—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.33e-05	0.000763	CbGpPWpGaD
Thiothixene—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.33e-05	0.000762	CbGpPWpGaD
Thiothixene—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.3e-05	0.000744	CbGpPWpGaD
Thiothixene—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.3e-05	0.000744	CbGpPWpGaD
Thiothixene—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.3e-05	0.000742	CbGpPWpGaD
Thiothixene—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.29e-05	0.00074	CbGpPWpGaD
Thiothixene—DRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.28e-05	0.000735	CbGpPWpGaD
Thiothixene—DRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.28e-05	0.000735	CbGpPWpGaD
Thiothixene—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.28e-05	0.000734	CbGpPWpGaD
Thiothixene—SLC22A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.28e-05	0.000731	CbGpPWpGaD
Thiothixene—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.27e-05	0.00073	CbGpPWpGaD
Thiothixene—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	1.25e-05	0.000716	CbGpPWpGaD
Thiothixene—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.25e-05	0.000715	CbGpPWpGaD
Thiothixene—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.24e-05	0.000709	CbGpPWpGaD
Thiothixene—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.23e-05	0.000705	CbGpPWpGaD
Thiothixene—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.23e-05	0.000704	CbGpPWpGaD
Thiothixene—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.23e-05	0.000704	CbGpPWpGaD
Thiothixene—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.23e-05	0.000702	CbGpPWpGaD
Thiothixene—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.22e-05	0.000698	CbGpPWpGaD
Thiothixene—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.22e-05	0.000697	CbGpPWpGaD
Thiothixene—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.21e-05	0.000694	CbGpPWpGaD
Thiothixene—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.21e-05	0.000693	CbGpPWpGaD
Thiothixene—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.21e-05	0.000692	CbGpPWpGaD
Thiothixene—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.17e-05	0.000673	CbGpPWpGaD
Thiothixene—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.17e-05	0.000669	CbGpPWpGaD
Thiothixene—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.14e-05	0.000653	CbGpPWpGaD
Thiothixene—HTR6—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.13e-05	0.00065	CbGpPWpGaD
Thiothixene—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.12e-05	0.000644	CbGpPWpGaD
Thiothixene—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.12e-05	0.000643	CbGpPWpGaD
Thiothixene—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.12e-05	0.000641	CbGpPWpGaD
Thiothixene—HTR6—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.12e-05	0.00064	CbGpPWpGaD
Thiothixene—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.12e-05	0.00064	CbGpPWpGaD
Thiothixene—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.11e-05	0.000635	CbGpPWpGaD
Thiothixene—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.11e-05	0.000634	CbGpPWpGaD
Thiothixene—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.1e-05	0.000633	CbGpPWpGaD
Thiothixene—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.1e-05	0.000632	CbGpPWpGaD
Thiothixene—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.1e-05	0.000632	CbGpPWpGaD
Thiothixene—HTR6—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.1e-05	0.000631	CbGpPWpGaD
Thiothixene—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.1e-05	0.000631	CbGpPWpGaD
Thiothixene—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.1e-05	0.000629	CbGpPWpGaD
Thiothixene—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.1e-05	0.000629	CbGpPWpGaD
Thiothixene—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.03e-05	0.000591	CbGpPWpGaD
Thiothixene—HTR6—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.02e-05	0.000586	CbGpPWpGaD
Thiothixene—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.02e-05	0.000585	CbGpPWpGaD
Thiothixene—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.01e-05	0.000581	CbGpPWpGaD
Thiothixene—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	1.01e-05	0.000581	CbGpPWpGaD
Thiothixene—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.01e-05	0.00058	CbGpPWpGaD
Thiothixene—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.01e-05	0.000577	CbGpPWpGaD
Thiothixene—HTR6—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1e-05	0.000573	CbGpPWpGaD
Thiothixene—DRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.77e-06	0.00056	CbGpPWpGaD
Thiothixene—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.69e-06	0.000555	CbGpPWpGaD
Thiothixene—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.69e-06	0.000555	CbGpPWpGaD
Thiothixene—DRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.62e-06	0.000551	CbGpPWpGaD
Thiothixene—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.54e-06	0.000546	CbGpPWpGaD
Thiothixene—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.54e-06	0.000546	CbGpPWpGaD
Thiothixene—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.52e-06	0.000545	CbGpPWpGaD
Thiothixene—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.52e-06	0.000545	CbGpPWpGaD
Thiothixene—DRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.48e-06	0.000543	CbGpPWpGaD
Thiothixene—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.23e-06	0.000529	CbGpPWpGaD
Thiothixene—DRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.8e-06	0.000504	CbGpPWpGaD
Thiothixene—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.68e-06	0.000497	CbGpPWpGaD
Thiothixene—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.68e-06	0.000497	CbGpPWpGaD
Thiothixene—DRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.61e-06	0.000493	CbGpPWpGaD
Thiothixene—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.4e-06	0.000481	CbGpPWpGaD
Thiothixene—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.36e-06	0.000479	CbGpPWpGaD
Thiothixene—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.27e-06	0.000474	CbGpPWpGaD
Thiothixene—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.23e-06	0.000471	CbGpPWpGaD
Thiothixene—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.15e-06	0.000467	CbGpPWpGaD
Thiothixene—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.11e-06	0.000464	CbGpPWpGaD
Thiothixene—ALB—Hemostasis—IL2—acquired immunodeficiency syndrome	8e-06	0.000458	CbGpPWpGaD
Thiothixene—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.57e-06	0.000433	CbGpPWpGaD
Thiothixene—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.53e-06	0.000431	CbGpPWpGaD
Thiothixene—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.4e-06	0.000424	CbGpPWpGaD
Thiothixene—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.38e-06	0.000422	CbGpPWpGaD
Thiothixene—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.36e-06	0.000422	CbGpPWpGaD
Thiothixene—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.26e-06	0.000416	CbGpPWpGaD
Thiothixene—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.26e-06	0.000416	CbGpPWpGaD
Thiothixene—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.24e-06	0.000415	CbGpPWpGaD
Thiothixene—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.16e-06	0.00041	CbGpPWpGaD
Thiothixene—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.15e-06	0.000409	CbGpPWpGaD
Thiothixene—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.13e-06	0.000409	CbGpPWpGaD
Thiothixene—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.04e-06	0.000403	CbGpPWpGaD
Thiothixene—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.03e-06	0.000402	CbGpPWpGaD
Thiothixene—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.64e-06	0.000381	CbGpPWpGaD
Thiothixene—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.6e-06	0.000378	CbGpPWpGaD
Thiothixene—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.54e-06	0.000374	CbGpPWpGaD
Thiothixene—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.52e-06	0.000374	CbGpPWpGaD
Thiothixene—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.5e-06	0.000372	CbGpPWpGaD
Thiothixene—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.5e-06	0.000372	CbGpPWpGaD
Thiothixene—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.41e-06	0.000367	CbGpPWpGaD
Thiothixene—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.39e-06	0.000366	CbGpPWpGaD
Thiothixene—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.38e-06	0.000365	CbGpPWpGaD
Thiothixene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	6.28e-06	0.00036	CbGpPWpGaD
Thiothixene—SLC22A1—Metabolism—ALB—acquired immunodeficiency syndrome	5.98e-06	0.000342	CbGpPWpGaD
Thiothixene—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.95e-06	0.000341	CbGpPWpGaD
Thiothixene—HTR6—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.91e-06	0.000338	CbGpPWpGaD
Thiothixene—HTR6—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.88e-06	0.000337	CbGpPWpGaD
Thiothixene—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.82e-06	0.000333	CbGpPWpGaD
Thiothixene—DRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.08e-06	0.000291	CbGpPWpGaD
Thiothixene—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	5.07e-06	0.00029	CbGpPWpGaD
Thiothixene—DRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.06e-06	0.00029	CbGpPWpGaD
Thiothixene—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.37e-06	0.00025	CbGpPWpGaD
Thiothixene—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.35e-06	0.000249	CbGpPWpGaD
Thiothixene—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.35e-06	0.000249	CbGpPWpGaD
Thiothixene—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.33e-06	0.000248	CbGpPWpGaD
Thiothixene—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.84e-06	0.00022	CbGpPWpGaD
Thiothixene—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.82e-06	0.000219	CbGpPWpGaD
Thiothixene—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.78e-06	0.000216	CbGpPWpGaD
Thiothixene—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.77e-06	0.000216	CbGpPWpGaD
Thiothixene—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.76e-06	0.000215	CbGpPWpGaD
Thiothixene—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.75e-06	0.000215	CbGpPWpGaD
Thiothixene—HTR6—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.47e-06	0.000199	CbGpPWpGaD
Thiothixene—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.44e-06	0.000197	CbGpPWpGaD
Thiothixene—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.42e-06	0.000196	CbGpPWpGaD
Thiothixene—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	3.3e-06	0.000189	CbGpPWpGaD
Thiothixene—DRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.99e-06	0.000171	CbGpPWpGaD
Thiothixene—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	2.8e-06	0.00016	CbGpPWpGaD
Thiothixene—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.57e-06	0.000147	CbGpPWpGaD
Thiothixene—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.56e-06	0.000146	CbGpPWpGaD
Thiothixene—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.26e-06	0.000129	CbGpPWpGaD
Thiothixene—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.22e-06	0.000127	CbGpPWpGaD
Thiothixene—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.22e-06	0.000127	CbGpPWpGaD
Thiothixene—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.02e-06	0.000116	CbGpPWpGaD
